Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Clonmel Healthcare Ltd, Waterford Road, Clonmel, Co. Tipperary, Ireland
Profloxin 250 mg film-coated Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White or yellowish 11 mm round biconvex, film-coated tablets. Scored on both sides and side wall scored, marked C250 on one side. The tablet can be divided into equal doses. |
One film-coated tablet contains ciprofloxacin hydrochloride equivalent to 250 mg ciprofloxacin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ciprofloxacin |
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
Blister strips consisting of 250 microM clear PVC and 20 microM hard temper aluminium foil contained in a carton.
Pack sizes: 5, 10, 12, 20, 30, 50, 60, 90 and 100 film-coated tablets.
Not all pack sizes may be marketed.
Clonmel Healthcare Ltd, Waterford Road, Clonmel, Co. Tipperary, Ireland
PA0126/203/001
Date of first authorisation: 28th January 2005
Date of last renewal: 28th January 2010
| Drug | Countries | |
|---|---|---|
| PROFLOXIN | Ireland, Malta, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
